Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND, May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri, May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC, May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson, May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker, May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
Human Papillomavirus Infection
Human Papillomavirus Vaccine
Human Papillomavirus (HPV)
Fear of Damaging LVAD Impairs Sex Life
May 14, 2013
Do patients with a left ventricular assist device (LVAD) have a worse sex life, afraid to damage it, or a better one, because they feel better? Either way, studies say, they should be encouraged to discuss the question.
Alternative Strategies May Help in IBS Self-Management
May 13, 2013
Evidence that both email and alternative therapies may help patients with irritable bowel syndrome, beyond the effects of medication.
Cultivating New Treatments in Follicular Lymphoma
May 10, 2013
Intensified therapy including CNS prophylaxis proves promising for reducing or delaying side effects in malignant B-cell lymphoma.
Antidepressants During Pregnancy Linked to Autism Risk
May 9, 2013
A population-based case control study leads to reason to believe that taking either a selective-serotonin reductase inhibitor (SSRI) or a non-selective monoamine reuptake inhibitor slightly increases the risks for autism among the offspring of pregnant women with a history of depression.
Vismodegib: Its Pros and Cons in Basal Cell Carcinoma
May 8, 2013
Experts offer an update on current research in hedgehog signaling pathway inhibition in basal cell carcinoma, including efficacy and toxicity results for vismodegib (Erivedge), the first oral medication to win FDA approval for metastatic BCC treatment.